{"name":"Chi Kong Li","slug":"chi-kong-li","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"CUCART19","genericName":"CUCART19","slug":"cucart19","indication":"Prevention of COVID-19","status":"phase_2"}]}],"pipeline":[{"name":"CUCART19","genericName":"CUCART19","slug":"cucart19","phase":"phase_2","mechanism":"CUCART19 is a monoclonal antibody targeting the SARS-CoV-2 spike protein.","indications":["Prevention of COVID-19"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2025-07-31","type":"pipeline","source":"South China Morning Post","summary":"Wuxi AppTec joins funding rush as appetite grows for China’s biotech - South China Morning Post","headline":"Wuxi AppTec joins funding rush as appetite grows for China’s biotech","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwJBVV95cUxQSmZOTTNDdmIyTG9CVTEzNm5qS3NHOEM1ZjMxemVWc21JY0VZZ0JPSXpTQVhOekJxay1iaDMxVEYzZm1WbXpRVFQzVm82cDExMVdKYnNzMUtHUUtBSFFla2VNczZHWDFKdTZSQ2dDZFdLTEhVRzdkRTgtclNyUzgxR1V1b0RXR2JIX2FHc0lDdkxTcUdLenE1RlhTbFM5S0xVVC1pQ2NSbldrbVQwSmV0NllqUG43MXJfem5MdlYzTFYxcHZGV0QzOTVIOUpBSTZKS2wydzBDVUlCampFT0hTYTk1V3I2UzJZVG9TYUZsWjB3aDZOaG43T09nOXhORXA5TG1qUFNkbkRiOWxXQ1pzVWRkbjVDMVg3UmdKMzNKYw?oc=5","date":"2024-01-24","type":"trial","source":"The Chinese University of Hong Kong","summary":"CU Medicine’s nationwide multicentre study on acute lymphoblastic leukaemia establishes a new biomarker to inform relapse risk and treatment strategies - The Chinese University of Hong Kong","headline":"CU Medicine’s nationwide multicentre study on acute lymphoblastic leukaemia establishes a new biomarker to inform relaps","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizgFBVV95cUxQT2tHR2NIc3Nwa3U1ekFZUUdmYjVFR1ZHNVBqS3NFOVQxaGZPaWVrNDM1TTVWNUYzcUpfbFZxTndHYnZjeHREOGhvM2tiSnZ2S21NYkthYzUwM3dESXZ3Z1hiRmpWMExSams3MHA0em5ZY0Y2M2JuLXd2WDhkTGppcy1YUFUtTS0xQml0eTJ6SjdMQ1cta3ZDQ04xLS1GbkZPeUZoVmpvV0ZINXpXcGtFSDE4T2NiTHZfNnA2QjhvRkMxV3V1Y1dWejJuSGJfZw?oc=5","date":"2021-06-01","type":"trial","source":"The Chinese University of Hong Kong","summary":"CUHK Study Finds Half of Childhood Cancer Survivors Used Complementary and Alternative Medicine - The Chinese University of Hong Kong","headline":"CUHK Study Finds Half of Childhood Cancer Survivors Used Complementary and Alternative Medicine","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2017-10-03","type":"pipeline","source":"South China Morning Post","summary":"Homegrown Hong Kong: Po Chai Pills, city’s go-to cure for everything - South China Morning Post","headline":"Homegrown Hong Kong: Po Chai Pills, city’s go-to cure for everything","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}